195 related articles for article (PubMed ID: 36968493)
1. Sex differences in hippocampal β-amyloid accumulation in the triple-transgenic mouse model of Alzheimer's disease and the potential role of local estrogens.
Hu YT; Chen XL; Zhang YN; McGurran H; Stormmesand J; Breeuwsma N; Sluiter A; Zhao J; Swaab D; Bao AM
Front Neurosci; 2023; 17():1117584. PubMed ID: 36968493
[TBL] [Abstract][Full Text] [Related]
2. Early growth response-1 regulates acetylcholinesterase and its relation with the course of Alzheimer's disease.
Hu YT; Chen XL; Huang SH; Zhu QB; Yu SY; Shen Y; Sluiter A; Verhaagen J; Zhao J; Swaab D; Bao AM
Brain Pathol; 2019 Jul; 29(4):502-512. PubMed ID: 30511454
[TBL] [Abstract][Full Text] [Related]
3. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
4. Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways.
Rosario ER; Carroll J; Pike CJ
Brain Res; 2010 Nov; 1359():281-90. PubMed ID: 20807511
[TBL] [Abstract][Full Text] [Related]
5. Sex-Dependent Differences in Spontaneous Autoimmunity in Adult 3xTg-AD Mice.
Kapadia M; Mian MF; Michalski B; Azam AB; Ma D; Salwierz P; Christopher A; Rosa E; Zovkic IB; Forsythe P; Fahnestock M; Sakic B
J Alzheimers Dis; 2018; 63(3):1191-1205. PubMed ID: 29710702
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
7. Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation.
Himeno E; Ohyagi Y; Ma L; Nakamura N; Miyoshi K; Sakae N; Motomura K; Soejima N; Yamasaki R; Hashimoto T; Tabira T; LaFerla FM; Kira J
Ann Neurol; 2011 Feb; 69(2):248-56. PubMed ID: 21387370
[TBL] [Abstract][Full Text] [Related]
8. Early-Onset Network Hyperexcitability in Presymptomatic Alzheimer's Disease Transgenic Mice Is Suppressed by Passive Immunization with Anti-Human APP/Aβ Antibody and by mGluR5 Blockade.
Kazim SF; Chuang SC; Zhao W; Wong RK; Bianchi R; Iqbal K
Front Aging Neurosci; 2017; 9():71. PubMed ID: 28392767
[TBL] [Abstract][Full Text] [Related]
9. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
10. Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease.
Vande Vyver M; Barker-Haliski M; Aourz N; Nagels G; Bjerke M; Engelborghs S; De Bundel D; Smolders I
Epilepsia; 2022 Oct; 63(10):2703-2715. PubMed ID: 35775150
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
12. Fyn knock-down increases Aβ, decreases phospho-tau, and worsens spatial learning in 3×Tg-AD mice.
Minami SS; Clifford TG; Hoe HS; Matsuoka Y; Rebeck GW
Neurobiol Aging; 2012 Apr; 33(4):825.e15-24. PubMed ID: 21741124
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
14. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
15. Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
Winton MJ; Lee EB; Sun E; Wong MM; Leight S; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2011 May; 31(21):7691-9. PubMed ID: 21613482
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta peptides stimulate the expression of the p75(NTR) neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice.
Chakravarthy B; Gaudet C; Ménard M; Atkinson T; Brown L; Laferla FM; Armato U; Whitfield J
J Alzheimers Dis; 2010; 19(3):915-25. PubMed ID: 20157247
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease.
Martínez-Drudis L; Sheta R; Pellegrinato R; Loukili S; Tremblay C; Calon F; Rivest S; Oueslati A
Neurobiol Dis; 2022 Oct; 172():105833. PubMed ID: 35905928
[TBL] [Abstract][Full Text] [Related]
18. 17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention.
Zhao L; Yao J; Mao Z; Chen S; Wang Y; Brinton RD
Neurobiol Aging; 2011 Nov; 32(11):1949-63. PubMed ID: 20053478
[TBL] [Abstract][Full Text] [Related]
19. Ca2+-permeable TRPV1 pain receptor knockout rescues memory deficits and reduces amyloid-β and tau in a mouse model of Alzheimer's disease.
Kim J; Lee S; Kim J; Ham S; Park JHY; Han S; Jung YK; Shim I; Han JS; Lee KW; Kim J
Hum Mol Genet; 2020 Jan; 29(2):228-237. PubMed ID: 31814000
[TBL] [Abstract][Full Text] [Related]
20. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
Wu X; Kosaraju J; Zhou W; Tam KY
Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
